CDK4/6 inhibitors in advanced breast cancer, what is beyond?

被引：4
作者：
Mohammed, Amrallah A. [1 ,2 ]
Rashied, Hanaa [3 ]
Elsayed, Fifi Mostafa [4 ]
机构：
[1] Zagazig Univ, Fac Med, Med Oncol Dept, 29 Saad Zaghloul, Zagazig 44519, Egypt
[2] King Salman Armed Forces Hosp, Tabuk City, Saudi Arabia
[3] El Mabra Hosp, Zagazig, Egypt
[4] Suez Canal Univ, Dept Fac Med, Clin Oncol & Nucl Med, Ismailia, Egypt
来源：
ONCOLOGY REVIEWS | 2019年 / 13卷 / 02期
关键词：
Breast cancer; CDK4/6; inhibitors; predictors of response and resistance; RIBOCICLIB PLUS LETROZOLE; KINASE; 4/6; INHIBITOR; 1ST-LINE TREATMENT; ENDOCRINE THERAPY; PALBOCICLIB; ABEMACICLIB; COMBINATION; RESISTANCE; FULVESTRANT; SUPPRESSION;
D O I：
10.4081/oncol.2019.416
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Resistant to hormonal treatment considered the main clinical challenge in the management of advanced breast cancer (ABC). The use of CDK4/6 inhibitors (CDK4/61) may change the treatment landscape. In this mandated review, we will focus on the applicable role of CDK4/6I in the management of HR+/HER2-ABC, mechanisms of resistance, and promising future implementation.
引用
收藏
页码：125 / 133
页数：9
相关论文
共 50 条
  • [1] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
    Andre, Fabrice
    Ciruelos, Eva
    Rubovszky, Gabor
    Campone, Mario
    Loibl, Sibylle
    Rugo, Hope S.
    Iwata, Hiroji
    Conte, Pierfranco
    Mayer, Ingrid A.
    Kaufman, Bella
    Yamashita, Toshinari
    Lu, Yen-Shen
    Inoue, Kenichi
    Takahashi, Masato
    Papai, Zsuzsanna
    Longin, Anne-Sophie
    Mills, David
    Wilke, Celine
    Hirawat, Samit
    Juric, Dejan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) : 1929 - 1940
  • [2] [Anonymous], 2018, CANC RES
  • [3] [Anonymous], 2018, CANCER RES, DOI DOI 10.1158/1538-7445.SABCS17-P1-09-01
  • [4] [Anonymous], CANC RES
  • [5] [Anonymous], 2003, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD002747
  • [6] [Anonymous], CELL
  • [7] Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer
    Barroso-Sousa, Romualdo
    Shapiro, Geoffrey I.
    Tolaney, Sara M.
    [J]. BREAST CARE, 2016, 11 (03) : 167 - 173
  • [8] Long-term management of patients with hormone receptor-positive metastatic breast cancer: Concepts for sequential and combination endocrine-based therapies
    Brufsky, Adam M.
    [J]. CANCER TREATMENT REVIEWS, 2017, 59 : 22 - 32
  • [9] Cellular mechanisms of tumour suppression by the retinoblastoma gene
    Burkhart, Deborah L.
    Sage, Julien
    [J]. NATURE REVIEWS CANCER, 2008, 8 (09) : 671 - 682
  • [10] The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
    Cerami, Ethan
    Gao, Jianjiong
    Dogrusoz, Ugur
    Gross, Benjamin E.
    Sumer, Selcuk Onur
    Aksoy, Buelent Arman
    Jacobsen, Anders
    Byrne, Caitlin J.
    Heuer, Michael L.
    Larsson, Erik
    Antipin, Yevgeniy
    Reva, Boris
    Goldberg, Arthur P.
    Sander, Chris
    Schultz, Nikolaus
    [J]. CANCER DISCOVERY, 2012, 2 (05) : 401 - 404
12345